| Price | 565.00p on 13-02-2026 at 18:55:06 |
|---|---|
| Change | -10.00p -1.74% |
| Buy | 600.00p |
| Sell | 530.00p |
| Last Trade: | Buy 250.00 at 569.75p |
| Day's Volume: | 12,016 |
| Last Close: | 565.00p |
| Open: | 575.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 565.00p - 575.00p |
| 52wk Range: | 560.00p - 1,200.00p |
| Market Capitalisation: | £87.49m |
| VWAP: | 554.21768p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 250 | 569.75p | Ordinary |
16:29:31 - 13-Feb-26 |
| Unknown* | 2,500 | 560.00p | Ordinary |
16:08:33 - 13-Feb-26 |
| Buy* | 9 | 600.00p | Ordinary |
15:46:33 - 13-Feb-26 |
| Buy* | 5 | 600.00p | SI Trade |
15:46:32 - 13-Feb-26 |
| Buy* | 3 | 600.00p | SI Trade |
15:46:32 - 13-Feb-26 |
| Buy* | 1,000 | 570.00p | Ordinary |
14:31:43 - 13-Feb-26 |
| Buy* | 5 | 570.00p | Ordinary |
14:22:07 - 13-Feb-26 |
| Buy* | 500 | 570.00p | Ordinary |
14:00:17 - 13-Feb-26 |
| Unknown* | 2,520 | 520.50p | Negotiated Trade |
13:31:55 - 13-Feb-26 |
| Buy* | 9 | 600.00p | Ordinary |
13:29:54 - 13-Feb-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
